IRIS
LUCCHESI, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.667
NA - Nord America 1.237
AS - Asia 908
SA - Sud America 157
Continente sconosciuto - Info sul continente non disponibili 94
AF - Africa 59
OC - Oceania 6
Totale 4.128
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.179
IT - Italia 580
RU - Federazione Russa 449
SG - Singapore 292
CN - Cina 222
IE - Irlanda 168
BR - Brasile 123
GB - Regno Unito 120
VN - Vietnam 111
HK - Hong Kong 88
DE - Germania 75
FR - Francia 57
KR - Corea 57
FI - Finlandia 54
SE - Svezia 43
IN - India 40
CA - Canada 36
ZA - Sudafrica 32
BD - Bangladesh 23
NL - Olanda 21
ES - Italia 19
PL - Polonia 13
IQ - Iraq 12
CH - Svizzera 11
AR - Argentina 10
AT - Austria 10
CZ - Repubblica Ceca 9
MX - Messico 9
UA - Ucraina 9
JP - Giappone 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 5
CI - Costa d'Avorio 5
DZ - Algeria 5
IL - Israele 5
RO - Romania 5
SA - Arabia Saudita 5
VE - Venezuela 5
JM - Giamaica 4
MY - Malesia 4
PK - Pakistan 4
AL - Albania 3
AU - Australia 3
BE - Belgio 3
CL - Cile 3
CO - Colombia 3
EC - Ecuador 3
ET - Etiopia 3
GR - Grecia 3
JO - Giordania 3
KE - Kenya 3
MA - Marocco 3
NZ - Nuova Zelanda 3
PE - Perù 3
PT - Portogallo 3
TH - Thailandia 3
TR - Turchia 3
AO - Angola 2
AZ - Azerbaigian 2
BO - Bolivia 2
EG - Egitto 2
IR - Iran 2
LT - Lituania 2
MD - Moldavia 2
NG - Nigeria 2
PY - Paraguay 2
UY - Uruguay 2
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
ID - Indonesia 1
KG - Kirghizistan 1
KW - Kuwait 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.036
Salva come PNG Salva come JPEG
Città #
Dallas 243
Singapore 171
Dublin 168
Milan 134
Moscow 133
San Jose 111
Siena 104
Ashburn 96
Hong Kong 83
Santa Clara 77
Hefei 73
Southend 73
Seoul 54
Chandler 52
Rome 51
Beijing 50
Florence 45
Los Angeles 40
Ho Chi Minh City 38
New York 34
Helsinki 30
Hanoi 29
Johannesburg 27
Fairfield 26
Council Bluffs 24
Lauterbourg 23
Munich 20
Frankfurt am Main 17
São Paulo 17
Montreal 16
The Dalles 16
Columbus 15
Houston 15
Orem 15
Ann Arbor 14
Princeton 14
Düsseldorf 13
Lappeenranta 13
Woodbridge 13
Buffalo 12
Dong Ket 11
Messina 11
Turku 11
Bengaluru 10
Seattle 10
Nuremberg 9
Warsaw 9
Cambridge 8
Denver 8
Redondo Beach 8
Shanghai 8
Tashkent 8
Tokyo 8
Toronto 8
Bologna 7
Brno 7
Brooklyn 7
Chennai 7
Figino 7
Jacksonville 7
London 7
Poggibonsi 7
Portsmouth 7
Atlanta 6
Bacoli 6
Chicago 6
Mumbai 6
Málaga 6
Naples 6
Stockholm 6
Abidjan 5
Baronissi 5
Cagliari 5
Chlef 5
Gurugram 5
Poplar 5
Rio de Janeiro 5
Agliana 4
Amsterdam 4
Baghdad 4
Barolo 4
Belo Horizonte 4
Brescia 4
Dearborn 4
Guangzhou 4
Lanciano 4
Madrid 4
Newark 4
Salerno 4
Vienna 4
Washington 4
Wilmington 4
Addis Ababa 3
Amman 3
Athens 3
Bari 3
Barquisimeto 3
Boston 3
Boydton 3
Brussels 3
Totale 2.550
Salva come PNG Salva come JPEG
Nome #
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 368
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 283
Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine 283
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses 236
Computational flow cytometry for characterizing the immune response in vaccine studies 233
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 222
Evidence of SARS-Cov-2-specific memory B cells six months after vaccination with BNT162b2 mRNA vaccine 199
Comparison of Immune Responses Elicited by BNT162b2, mRNA-1273 and ChAdOx1 COVID-19 Vaccines. 195
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability 192
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration 189
Transcriptomic analysis after SARS-CoV-2 mRNA vaccination reveals a specific gene signature in low-responder hemodialysis patients 187
From bivariate to multivariate analysis of cytometric data: overview of computational methods and their application in vaccination studies 181
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine 177
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses 160
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine 159
Vaccinazione anti SARSCov2 in una coorte di pazienti sottoposti a trapianto di cuore o di polmone: risposta umorale a dosi booster 152
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant 150
Successivi booster vaccinali contro SARS-CoV-2: risposta umorale in pazienti sottoposti a trapianto di cuore o di polmone 136
Third Sars-CoV-2 vaccine dose: B cell and antibody responses following heterologous and homologous vaccination strategies. 118
Persistence of spike-specific memory B cells and antibodies nine months after two doses of BNT162b2 mRNA vaccine. 114
Longitudinal profiling of spike-specific antibody and B cell responses following mRNA-1273 SARS-CoV-2 vaccination in hematopoietic cell transplantation recipients 101
Machine learning approaches to dissect hybrid and vaccine-induced immunity 30
Unexpectedly competent immune response to SARS-CoV-2 vaccination in Rett syndrome 25
In vitro cellular tropism and immunomodulatory response to rVSVΔG-ZEBOV-GP in human cells derived from tissues associated with adverse events 21
Booster dose reshapes SARS-CoV-2 RBD-specific B cell immunity in people living with HIV 17
Totale 4.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.339
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022128 0 18 6 5 4 3 10 2 12 7 31 30
2022/2023257 18 31 36 20 16 33 8 21 21 12 30 11
2023/2024386 8 4 36 46 21 88 109 16 10 11 10 27
2024/2025834 44 27 90 39 83 39 37 49 98 48 76 204
2025/20262.166 157 264 238 317 397 64 215 65 90 119 106 134
2026/2027109 98 11 0 0 0 0 0 0 0 0 0 0
Totale 4.128